Physician profile
Norman C Wang
NPI 1801064068
$13,540.97
in general payments reported to CMS, 2019-2025
10 companies · $743 in 2025
The $743 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,538 · 2020: $3,132 · 2021: $821 · 2022: $5.60 · 2023: $2.88 · 2024: $299 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $572 · Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $571.73 |
| Food and Beverage | $472.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,916.93 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite |
| Medtronic, INC. | $959.13 | 2021-2024 | Micra, Selectsecure, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $441.17 | 2019 | |
| Atricure, INC. | $105.65 | 2021 | |
| Cardiva Medical, INC. | $37.07 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Biosense Webster, INC. | $34.66 | 2022-2024 | Na |
| E.R. Squibb & Sons, L.L.C. | $17.66 | 2025 | Camzyos |
| Boston Scientific Corporation | $15.73 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.09 | 2024 | Lifevest |
| Elutia, INC. | $2.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.